African Focus
-
South Africa’s COVID-19 variant should be high on the agenda for the international community
The South African COVID-19 variant, 501.V2, is spreading faster than the UK’s strain but has received far less global attention. Discover why experts warn it should be a top priority for the international community.
-
COVID-19 vaccine – how will Africa keep it cold enough?
As Africa awaits its COVID-19 vaccines, the next hurdle is ensuring they stay cold—sometimes well below freezing—throughout the journey. How will South Africa and its neighbours overcome these critical storage and shipping challenges to keep doses safe and effective for millions? Discover the race to protect the continent.
-
Pfizer appoints new regional president for Africa and the Middle East
Pfizer has named Patrick van der Loo as its new regional president for Africa and the Middle East, tasking him with driving innovation in fast-growing markets. Discover how his leadership aims to advance breakthrough treatments and strengthen Pfizer’s commitment to patients across the region.
-
Team Europe contributes €500 million to COVAX initiative
Team Europe is backing global access to COVID-19 vaccines with a €500 million contribution to the COVAX initiative, helping protect vulnerable communities worldwide. Discover how this funding will speed up vaccine delivery to those who need it most.
-
Looking at Africa beyond COVID-19
Discover why African researchers say the continent shouldn’t just recover from COVID-19, but aim for even greater economic success. Explore bold ideas that could shape a stronger, more resilient Africa beyond the pandemic.
-
Goodbye Malaria joins the #AfricaMaskWeek initiative
Goodbye Malaria is proudly backing #AfricaMaskWeek, urging all Africans to keep wearing masks as COVID-19 remains a threat. Discover how their unique shweshwe masks help protect communities and boost local economies—find out how you can be part of the movement.
-
IPR waiver decision does not change India’s crucial role in supply of COVID-19 drugs
India’s vital role as a global supplier of COVID-19 drugs and vaccines remains steady despite resistance to the IPR waiver. With growing production capacity and international support, India is central to efforts making treatments more accessible—especially for developing nations. Discover why this decision could reshape global healthcare access.
-
J&J looks to Aspen to manufacture investigational COVID-19 vaccine candidate
Aspen Pharmacare is set to prioritise manufacturing Johnson & Johnson’s COVID-19 vaccine candidate in Port Elizabeth, pending final agreements. Discover how this partnership could boost South Africa’s role in the global vaccine supply chain.
-
Symrise South Africa appoints Teresa Orlanov as MD
Symrise South Africa welcomes Teresa Orlanov as its new Managing Director, bringing fresh leadership and a passion for growth to the region’s flavours, fragrances, and cosmetic ingredients market. Discover how her vision is set to drive customer success and innovation across sub-Saharan Africa.
-
Nigeria Society of Cosmetic Chemists becomes 50th IFSCC member
The Nigerian Society of Cosmetic Scientists has joined the IFSCC as its 50th member, marking a significant milestone driven by the dynamic growth of Nigeria’s cosmetics sector. Discover how this new membership is set to shape the future of beauty science in Africa and beyond.
-
South African skin care brand joins hands for World Food Day 2020
Discover how Environ Skin Care’s #EnvironCares campaign is helping fight childhood hunger this World Food Day. See how your support can provide vital meals to vulnerable South African children and make a real difference.
-
New dates for MAGHREB PHARMA
MAGHREB PHARMA Expo returns with new dates, as Algeria aims to boost drug exports to $5 billion by 2025. Don’t miss Africa’s top pharmaceutical technology event from 9–11 February 2021—discover the innovations and partnerships shaping the future of medicine in North Africa.
